Duke scientists discover possible effective component necessary for an HIV vaccine
Researchers at Duke have published new work in a scientific journal, showing that a potential HIV vaccine component proves effective in primate study.
Read MorePosted by Jason Parker | Sep 17, 2022
Researchers at Duke have published new work in a scientific journal, showing that a potential HIV vaccine component proves effective in primate study.
Read MorePosted by Jason Parker | Jun 6, 2022
The U.S. Food and Drug Administration (FDA) has approved an MMR vaccine developed by GlaxoSmithKline for use in America for those above the age of one.
Read MorePosted by WRAL News | Jul 30, 2020
Velocity said over 10,000 volunteers are already being recruited from a diverse set of communities and dosing began on July 27, officially launching the critical phase III stage of COVID-19 vaccine studies.
Read MorePosted by WRAL News | Jul 29, 2020
RESEARCH TRIANGLE PARK, N.C. – For the second time in three days, the Trump administration focused its attention on coronavirus vaccine development work being done in North Carolina. Following in the footsteps of President Donald Trump, who toured a Morrisville plant on Monday where a vaccine candidate is being...
Read MorePosted by Jodi Leese Glusco | Apr 6, 2020
Most public officials have made clear not to expect a vaccine in the next few months. Even with an accelerated timetable, it takes time to make certain that a vaccine is safe and effective.
Read MorePosted by WRAL TechWire | Jan 21, 2020
The National Institutes of Health is working on a vaccine against the new virus that has infected hundreds and killed four in Asia. But it won’t be available anytime soon.
Read More